1 research outputs found

    Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-Ī±

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>In addition to cytotoxic mechanisms directly impacting neurons, Ī²-amyloid (AĪ²)-induced glial activation also promotes release of proinflammatory molecules that may self-perpetuate reactive gliosis and damage neighbouring neurons, thus amplifying neuropathological lesions occurring in Alzheimer's disease (AD). Palmitoylethanolamide (PEA) has been studied extensively for its anti-inflammatory, analgesic, antiepileptic and neuroprotective effects. PEA is a lipid messenger isolated from mammalian and vegetable tissues that mimics several endocannabinoid-driven actions, even though it does not bind to cannabinoid receptors. Some of its pharmacological properties are considered to be dependent on the expression of peroxisome proliferator-activated receptors-Ī± (PPARĪ±).</p> <p>Findings</p> <p>In the present study, we evaluated the effect of PEA on astrocyte activation and neuronal loss in models of AĪ² neurotoxicity. To this purpose, primary rat mixed neuroglial co-cultures and organotypic hippocampal slices were challenged with AĪ²<sub>1-42 </sub>and treated with PEA in the presence or absence of MK886 or GW9662, which are selective PPARĪ± and PPARĪ³ antagonists, respectively. The results indicate that PEA is able to blunt AĪ²-induced astrocyte activation and, subsequently, to improve neuronal survival through selective PPARĪ± activation. The data from organotypic cultures confirm that PEA anti-inflammatory properties implicate PPARĪ± mediation and reveal that the reduction of reactive gliosis subsequently induces a marked rebound neuroprotective effect on neurons.</p> <p>Conclusions</p> <p>In line with our previous observations, the results of this study show that PEA treatment results in decreased numbers of infiltrating astrocytes during AĪ² challenge, resulting in significant neuroprotection. PEA could thus represent a promising pharmacological tool because it is able to reduce AĪ²-evoked neuroinflammation and attenuate its neurodegenerative consequences.</p
    corecore